General MedicationsORALStandard
VELSIPITY
ETRASIMOD ARGININE
Standard Dose
EQ 2MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VELSIPITY is listed in Drugs@FDA under application 216956 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ETRASIMOD ARGININE Form and strength TABLET;ORAL - EQ 2MG BASE Sponsor PFIZER Submission history Latest submission status date: 2025-08-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview VELSIPITY is listed in Drugs@FDA under application 216956 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETRASIMOD ARGININE Form and strength TABLET;ORAL - EQ 2MG BASE Sponsor PFIZER Submission history Latest submission status date: 2025-08-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.